A multidisciplinary research team has found a new use for a reliable medical device. Multiple heart patients have already benefited for the group’s outside-the-box thinking.

The high-risk patients who require urgent or emergent TAVR are often excluded from major clinical trials. To learn more about this population, researchers explored data from nearly 600 patients treated at high-volume facilities. 

Meanwhile members of Gen Z are twice as likely as other generations to get sneaky about their use of medical AI. 

In a Final Rule revealed last week, the Centers for Medicare & Medicaid Services outlined its plan to exchange medical records, diagnostic images and clinical notes electronically using secure protocols. Once the rule is published in the Federal Register, any HIPAA-covered entity that interacts with Medicare will have two years to follow CMS into the modern age.

ImmunityBio, the developer of bladder cancer treatment Anktiva, is accused by the U.S. Food and Drug Administration of disseminating “false or misleading information” about the drug's efficacy in an advertisement and podcast. The FDA said it’s not the first time it's sent a warning letter to the company’s executives over allegedly inaccurate claims.

U.S. healthcare will know it’s gotten AI right when the technology demonstrably improves care access, attentiveness and outcomes for the least financially healthy among us. 

A new acellular tissue-engineered vessel developed by Vascudyne could provide surgeons with a safe, effective alternative to saphenous vein grafts.

Several U.S. medical societies have collaborated on a new report advocating for better safety standards in cardiac catheterization labs. As one cardiologist described it, clinicians have shifted from "accepting risk" to "expecting better."